CRTX

Cortexyme News - CRTX

Best deals to access real time data!
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
North American Extreme
Monthly Subscription
for only
US$104.50
USA Big Cap Pro
Monthly Subscription
for only
US$52.04
VAT not included
Stock Name Stock Symbol Market Stock Type
Cortexyme Inc CRTX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.13 1.3% 10.12 10:13:51
Open Price Low Price High Price Close Price Previous Close
10.00 9.9508 10.38 9.99
more quote information »

Recent News

Date Time Source Heading
1/05/202216:09EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202215:58EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202215:50EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202215:40EDGARStatement of Changes in Beneficial Ownership (4)
12/27/202108:06SEEKCortexyme in pact with Jefferies to sell up to $150M worth..
12/23/202116:27EDGARCurrent Report Filing (8-k)
12/23/202116:25EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/10/202113:35EDGARSchedule 13g
11/23/202107:00BWCortexyme to Present at 4th Annual Evercore ISI HealthCONx..
11/12/202117:47EDGARStatement of Changes in Beneficial Ownership (4)
11/11/202110:52SEEKCortexyme posts more data from Alzheimer’s trial to show..
11/11/202110:30BWCortexyme’s Atuzaginstat Slowed Cognitive Decline in..
11/04/202107:00BWCortexyme to Present Additional Top-line GAIN Trial Results..
10/29/202108:03EDGARQuarterly Report (10-q)
10/26/202115:12EDGARCurrent Report Filing (8-k)
10/26/202115:01BWCortexyme Reports GAIN Trial Data Demonstrated Relationship..
10/15/202121:04SEEKJasper more than doubles while M&A headlines weekly..
10/08/202111:04EDGARSchedule 13g
10/07/202117:24EDGARStatement of Changes in Beneficial Ownership (4)
9/27/202107:00BWCortexyme to Present Results from the GAIN Trial: A Phase..
9/08/202108:45SEEKCortexyme gets dosing underway in early-stage COR588 trial
9/08/202107:00BWCortexyme Expands Proprietary Development Pipeline with..
9/07/202107:00BWCortexyme to Present at H.C. Wainwright 23rd Annual Global..
8/25/202107:00BWCortexyme Presents New Data Demonstrating Evidence of P...
8/18/202116:30EDGARStatement of Changes in Beneficial Ownership (4)
8/18/202116:25EDGARStatement of Changes in Beneficial Ownership (4)
8/18/202107:00BWCortexyme to Present at Annual Biomarkers for Alzheimer’s..
8/12/202116:37EDGARStatement of Changes in Beneficial Ownership (4)
8/09/202107:00BWCortexyme Provides Business Update and Reports Second..
8/04/202107:00BWCortexyme to Present at Canaccord Genuity' s 41st Annual..
7/26/202108:05BWCortexyme Presents Data Linking P. Gingivalis to Elevated..
7/26/202103:19TRMNCortexyme Develops 3CLpro Inhibitor to Treat COVID-19..
7/23/202107:09SEEKCortexyme picks lead 3CLpro inhibitor for the treatment of..
7/23/202107:00BWCortexyme Announces Lead 3CLpro Inhibitor for the Treatment..
7/22/202107:00BWCortexyme to Present New Data at AAIC 2021
7/21/202107:00BWCortexyme Presents New Data Demonstrating Atuzaginstat..
7/19/202107:00BWCortexyme to Host Symposium at AAIC 2021
7/16/202114:00SEEKSeeking Alpha Catalyst Watch
6/30/202116:47EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202105:05EDGARCurrent Report Filing (8-k)
6/17/202118:32EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202118:28EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202118:25EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202107:00BWCortexyme to Present at Investor Conferences in June 2021
5/18/202115:08EDGARCurrent Report Filing (8-k)
5/12/202115:52EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202107:21SEEKCortexyme EPS beats by $0.02
5/04/202107:00BWCortexyme to Present at the BofA Securities 2021 Healthcare..
4/30/202115:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
See more news about this stock »
Your Recent History
NASDAQ
CRTX
Cortexyme
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220119 16:29:08